Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study

氨基水杨酸 医学 置信区间 溃疡性结肠炎 胃肠病学 灌肠 内科学 随机对照试验 疾病
作者
Livia Biancone,Paolo Gionchetti,G. Del Vecchio Blanco,Ambrogio Orlando,Vito Annese,Claudio Papi,R. Sostegni,R. D’Incà,C. Petruzziello,Angelo Casà,Giuseppe Sica,Emma Calabrese,Massimo Campieri,Francesco Pallone
出处
期刊:Digestive and Liver Disease [Elsevier BV]
卷期号:39 (4): 329-337 被引量:55
标识
DOI:10.1016/j.dld.2007.01.012
摘要

Topical beclomethasone diproprionate has shown efficacy in ulcerative colitis.To assess, in a multicenter, randomized, double-blind study, the tolerability and safety of topical beclomethasone diproprionate (3mg) enema and foam versus mesalazine (2g) enema and foam in mild-moderate distal ulcerative colitis.In 15 referral gastrointestinal units, 99 patients with distal ulcerative colitis were enrolled. This number was lower than planned according to the statistical analysis, due to a low recruitment rate.Patients were randomly assigned to random preparations (beclomethasone diproprionate enema, beclomethasone diproprionate foam, mesalazine enema, mesalazine foam) once nightly for 8 weeks, with clinical and endoscopical assessment (Disease Activity Index score) at baseline (T0), 4 (T4) and 8 weeks (T8). Results were expressed as median and range (95% confidence interval). The efficacy was assessed by comparing the Disease Activity Index value at T4 and T8 by using the Student's t-test or the Wilcoxon-Mann-Whitney test.Efficacy was comparable in the beclomethasone diproprionate or mesalazine groups at both T4 and T8 (response at T4: beclomethasone diproprionate 78% [95% confidence interval 0.6-0.8] versus mesalazine 79% [95% confidence interval 0.6-0.8]; T8: beclomethasone diproprionate 84% [95% confidence interval 0.7-0.9] versus mesalazine 90% [95% confidence interval 0.7-1.0]; p=n.s.; remission at T4: beclomethasone diproprionate 24% [95% confidence interval 0.1-0.3] versus mesalazine 28% [95% confidence interval 0.1-0.3]; remission at T8: beclomethasone diproprionate 36% [95% confidence interval 0.2-0.5] versus mesalazine 52% [95% confidence interval 0.3-0.6]; p=n.s.). The Disease Activity Index lowered at T4 and T8 versus T0 in the four groups (T4 versus T0: beclomethasone diproprionate foam Disease Activity Index 2 versus 6 p<0.0001; beclomethasone diproprionate enema 4 versus 6, mesalazine enema 3 versus 6, mesalazine foam 3.5 versus 7, p<0.001 for all three groups; T8 versus T0: p<0.01). The Disease Activity Index lowered at T8 versus T4 in the beclomethasone diproprionate enema and foam (Disease Activity Index: 2 versus 4 and 1 versus 4, respectively; p<0.05) and in the mesalazine enema (Disease Activity Index: 1.5, range 0-4 versus 3, range 0-12; p<0.01), but not in the mesalazine foam group (Disease Activity Index: 1, range 0-9 versus 3.5, range 0-8; p=n.s.). The safety profile was favourable for all groups.Beclomethasone diproprionate and mesalazine enema and foam show a comparable tolerability and efficacy in mild active distal ulcerative colitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
JULY完成签到,获得积分10
2秒前
2秒前
2秒前
oo完成签到,获得积分10
2秒前
xiang发布了新的文献求助10
3秒前
荔枝完成签到,获得积分10
3秒前
3秒前
七月不远发布了新的文献求助10
3秒前
Clover04的应助被拓跋平萱采纳,获得10
4秒前
不解释发布了新的文献求助10
5秒前
安安发布了新的文献求助10
6秒前
毛果完成签到,获得积分10
6秒前
慧慧发布了新的文献求助10
6秒前
xiao发布了新的文献求助10
6秒前
7秒前
oo发布了新的文献求助10
7秒前
CipherSage的应助被坚定的采波采纳,获得10
8秒前
10秒前
11秒前
周少完成签到,获得积分10
11秒前
12秒前
耶耶耶完成签到,获得积分10
12秒前
12秒前
李健的应助被不一样的烟火采纳,获得30
13秒前
杨学良完成签到 ,获得积分10
13秒前
14秒前
小二郎的应助被369ninja采纳,获得10
14秒前
14秒前
mickle完成签到,获得积分10
15秒前
英姑的应助被眯眯眼的幻莲采纳,获得10
16秒前
杨lan完成签到 ,获得积分10
16秒前
16秒前
wo就是我发布了新的文献求助20
16秒前
youkang发布了新的文献求助10
17秒前
18秒前
18秒前
dmdgling发布了新的文献求助10
18秒前
paul发布了新的文献求助20
18秒前
希望天下0贩的0的应助被奇遇采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184336
求助须知:如何正确求助?哪些是违规求助? 9573358
关于积分的说明 21830993
捐赠科研通 7781367
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558401
邀请新用户注册赠送积分活动 2480846